XGN_OUT_1 [2025-04-02 10:40:37 -0400] 2088 Bytes | 610 tokens | Cum: 610 tkns (7.62% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 10:40:36 AM on Wed Apr 02, 2025 -0400, and I'm firing up the spotlight on Exagen (XGN), moving from 3.93 to 4.499. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

--- COMPANY PROFILE ---
Company: Exagen (XGN)
IPO: IPO date unknown
Shares Outstanding: 17,900,000
Industry: SERVICES-MEDICAL LABORATORIES
Exchange: XNAS

Here's the first list of news for Exagen:

C1 - Mar-12-25 03:04AM - Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives
C2 - Mar-12-25 03:04AM 12:10AM - Q4 2024 Exagen Inc Earnings Call
C3 - Mar-11-25 09:15AM - Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
C4 - Mar-11-25 09:15AM 08:00AM - Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights
C5 - Feb-25-25 04:05PM - Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025
C6 - Feb-05-25 06:38AM - Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?
C7 - Feb-04-25 04:05PM - Exagen Inc. to Participate in Upcoming Investor Conferences
C8 - Jan-12-25 12:00PM - Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Exagen (XGN)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

XGN_OUT_3 [2025-04-02 10:40:41 -0400] 1102 Bytes | 322 tokens | Cum: 934 tkns (11.68% of 8k)
==========================================================================

Showing C4 (chunk 1 of 10): C4:
**Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights**
Date: Mar-11-25 09:15AM 08:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/11/3040503/32920/en/Exagen-Inc-Reports-Strong-Fourth-Quarter-and-Full-Year-2024-Results-and-Business-Highlights.html

March 11, 2025 08:00 ET| Source:Exagen Inc.Exagen Inc.

Delivered record full-year total revenue and AVISE CTD average selling priceImproved full-year adjusted EBITDA loss and cash use by over 40%Commercialized new biomarkers to enhance clinical utility of AVISE CTD

CARLSBAD, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today reported financial results for the fourth quarter and full year ended December 31, 2024, and recent business highlights.

“The execution of our operational turnaround cont

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XGN_OUT_5 [2025-04-02 10:40:42 -0400] 829 Bytes | 264 tokens | Cum: 1274 tkns (15.93% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-31T05:13:54Z - Short Interest in Exagen Inc. (NASDAQ:XGN) Drops By 23.5%...
A2 - 2025-03-16T08:04:22Z - Short Interest in Exagen Inc. (NASDAQ:XGN) Decreases By 29.2%...
A3 - 2025-03-15T10:53:59Z - Cantor Fitzgerald Reduces Earnings Estimates for Exagen...
A4 - 2025-03-15T10:20:26Z - William Blair Forecasts Exagen's Q1 Earnings (NASDAQ:XGN)...
A5 - 2025-03-14T11:43:41Z - William Blair Predicts Exagen's FY2026 Earnings (NASDAQ:XGN)...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

XGN_OUT_7 [2025-04-02 10:40:49 -0400] 1098 Bytes | 341 tokens | Cum: 1617 tkns (20.21% of 8k)
==========================================================================

Showing A1 (chunk 1 of 5): A1:
**Short Interest in Exagen Inc. (NASDAQ:XGN) Drops By 23.5%**Date: 2025-03-31Source: {'uri': 'marketbeat.com', 'dataType': 'news', 'title': 'Market Beat'}URL: https://www.marketbeat.com/instant-alerts/short-interest-in-exagen-inc-nasdaqxgn-drops-by-235-2025-03-31/Exagen Inc. (NASDAQ:XGN - Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 17,600 shares, a decrease of 23.5% from the February 28th total of 23,000 shares. Based on an average daily trading volume, of 146,200 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.2% of the shares of the stock are short sold.

Shares of Exagen stock opened at $3.84 on Monday. The company has a debt-to-equity ratio of 1.54, a current ratio of 4.05 and a quick ratio of 4.05. The business has a 50 day simple moving average of $3.90 a

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XGN_OUT_9 [2025-04-02 10:40:51 -0400] 801 Bytes | 275 tokens | Cum: 2050 tkns (25.62% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-06-13T12:50:02Z - Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors
B2 - 2024-06-10T12:03:00Z - Time to Play 5 Top-Ranked Stocks With Rising P/E?
B3 - 2024-05-13T13:10:02Z - Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
B4 - 2024-05-07T21:10:03Z - Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
B5 - 2024-04-30T20:05:00Z - Exagen to Announce First Quarter 2024 Results on May 13, 2024
B6 - 2024-04-26T12:30:00Z - Exagen Inc. Announces Changes to the Board of Directors

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

XGN_OUT_11 [2025-04-02 10:40:54 -0400] 686 Bytes | 191 tokens | Cum: 2243 tkns (28.04% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors**Date: Unknown DateSource: Unknown SourceURL: https://www.zacks.com/stock/news/2287718/why-fast-paced-mover-exagen-xgn-is-a-great-choice-for-value-investorsIf you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Exagen (XGN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XGN_OUT_13 [2025-04-02 10:40:55 -0400] 1100 Bytes | 276 tokens | Cum: 2576 tkns (32.20% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S2 - 2025-03-11 10-K Item 7. Management's Discussion and Analysis of Fin Cond and Results of Oper.

You should read the following discussion of our financial condition and results of operations in conjunction with the financial statements and the notes thereto included elsewhere in...

S3 - 2025-03-11 8-K Item 2.02. Results of Oper and Fin Cond.

On March 11, 2025 , the Company reported its financial results for the quarter and year ended December 31, 2024. A copy of the press release issued by the Company is furnished as Exhibit 99.1 to this report.

The inform...

S7 - 2025-01-13 8-K Item 2.02 Results of Oper and Fin Cond.

On January 12, 2025, Exagen Inc. (the Company) announced in a press release (the Press Release) certain select preliminary unaudited financial information and results of operations for the three months and year ended Dece...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

XGN_OUT_15 [2025-04-02 10:40:56 -0400] 1098 Bytes | 222 tokens | Cum: 2800 tkns (35.00% of 8k)
==========================================================================

Showing S2 (chunk 1 of 6): S2:
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion of our financial condition and results of operations in conjunction with the financial statements and the notes thereto included elsewhere in this Annual Report. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report, including information with respect to our plans and strategy for our business and financial performance, includes forward-looking statements that are based on current beliefs, plans and expectations and involve risks, uncertainties and assumptions. You should read the "Special note regarding forward-looking statements" and "Risk Factors" section of this Annual Report for a discussion of important factors that could cause our actual results to differ materially from the results de

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

XGN_OUT_17 [2025-04-02 10:41:06 -0400] 4864 Bytes | 1451 tokens | Cum: 4253 tkns (53.16% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+-------------------------+-----------------------+
| Volume: 55,442 | Perf Month: 53.82% | Option/Short: Yes / Yes | Sales Y/Y TTM: 5.89% |
+---------------------+-----------------------+-------------------------+-----------------------+
| Avg Volume: 153.95K | Perf Quarter: 8.18% | Short Float: 0.19% | ROE: -93.78% |
+---------------------+-----------------------+-------------------------+-----------------------+
| Rel Volume: 1.96 | Index: - | Short Ratio: 0.11 | ROI: -48.47% |
+---------------------+-----------------------+-------------------------+-----------------------+
| RSI (14): 63.54 | Market Cap: 82.87M | Short Interest: 0.02M | Sales Surprise: 0.45% |
+---------------------+-----------------------+-------------------------+-----------------------+
| ATR (14): 0.54 | Shs Outstand: 17.64M | Beta: 1.62 | EPS Surprise: 21.87% |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA20: 25.53% | Shs Float: 9.17M | Sales Q/Q: -0.80% | P/E: - |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA50: 18.75% | Inst Own: 33.76% | Sales past 5Y: 6.91% | Earnings: Mar 11 BMO |
+---------------------+-----------------------+-------------------------+-----------------------+
| SMA200: 42.33% | Insider Own: 48.77% | Employees: 209 | |
+---------------------+-----------------------+-------------------------+-----------------------+
| Perf Week: 8.94% | Insider Trans: -5.45% | Debt/Eq: 2.45 | |
+---------------------+-----------------------+-------------------------+-----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: EXAGEN INC. (XGN) by NMSIC Co-Investment Fund, L.P. (Unknown Title) on 2025-03-25
- Common Stock: 350000 shares at $3.3 (I)

Inside Trans: EXAGEN INC. (XGN) by ABALLI JOHN (President and CEO) on 2025-02-28
- Common Stock: 8621 shares at $2.465 (D)

Inside Trans: EXAGEN INC. (XGN) by ABALLI JOHN (President and CEO) on 2025-02-21
- Common Stock: 112500 shares at $0 (D)
- Stock Option(right to buy): 75000 shares at $3.58 (D)

Inside Trans: EXAGEN INC. (XGN) by Black Jeffrey G. (Chief Financial Officer) on 2025-02-21
- Common Stock: 15000 shares at $0 (D)
- Stock Option(right to buy): 10000 shares at $3.58 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 55641000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -15115000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 4.33
Average Volume: 115629.48
30-Day High: 4.33
30-Day Low: 2.85

[Detailed Financials: TTM 2024]
- Total Assets: $44,689,000.0
- Total Liabilities: $35,149,000.0
- Total Equity: $9,540,000.0
- Current Assets: $36,455,000.0
- Current Liabilities: $13,506,000.0

[Income Statement: TTM 2024]
- Revenue: $55,641,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.83

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-14,457,000.0

[Detailed Financials: FY 2024]
- Total Assets: $44,689,000.0
- Total Liabilities: $35,149,000.0
- Total Equity: $9,540,000.0
- Current Assets: $36,455,000.0
- Current Liabilities: $13,506,000.0

[Income Statement: FY 2024]
- Revenue: $55,641,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.83

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-14,457,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

XGN_OUT_19 [2025-04-02 10:41:07 -0400] 676 Bytes | 167 tokens | Cum: 4632 tkns (57.90% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

XGN_IN_21 [2025-04-02 10:41:08 -0400] 126 Bytes | 29 tokens | Cum: 4689 tkns (58.61% of 8k)
==========================================================================

====================================
[2025-04-02 10:41:08] # Analysis Completed
Elapsed Time: 31.79 seconds